InvestorsHub Logo
Followers 65
Posts 23947
Boards Moderated 0
Alias Born 11/23/2016

Re: McMagyar post# 122757

Sunday, 10/01/2017 9:06:01 AM

Sunday, October 01, 2017 9:06:01 AM

Post# of 462960
No problem!

I do agree that the Ariana KEM analysis may well hold the key to a successful P2/3 trial design with optimum chance of meeting the right endpoints.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News